I started XpertPatient.com with one belief: a new cancer patient who understands their diagnosis and treatment options will achieve a better outcome. Years into this work, I’ve come to believe something just as important — that real understanding rarely comes from a pamphlet, a search engine at 2 a.m., or even a well-meaning clinician rushing through a fifteen-minute appointment. It comes from someone who can look a newly diagnosed patient in the eye and say, “I’ve been there. Let me show you where to start.”

That belief is why we built XpertGuided, which we call the first-ever survivor-led cancer education experience. But I didn’t arrive at this idea in a vacuum. The more I’ve looked at what’s happening across oncology — in research, in hospital systems, in the data on peer support — the clearer it becomes that survivor-led guidance isn’t a nice add-on to cancer care. It’s becoming the standard the rest of health education needs to catch up to.

A record number of survivors — and a system still catching up

The scale of the need has never been larger. For the first time, 70% of people diagnosed with cancer are now surviving at least five years, according to the American Cancer Society’s most recent Cancer Statistics report — and for many cancers caught early, five-year survival tops 90%. As of early 2025, an estimated 18.6 million people in the United States were living with a history of cancer, a population projected to grow past 22 million by 2035. That’s nearly 1,000 people entering survivorship every single day.

Dr. Arif Kamal, chief patient officer at the American Cancer Society, frames this as a fundamental shift: cancer care used to be defined by a “story of struggle,” he said, but is now shifting into “a story of survivorship.” Nicole Stout, DPT, the Society’s senior director of survivorship and wellness, argues that survivorship can no longer be treated as a phase that begins only after treatment ends. She contends that survivorship actually starts the moment of diagnosis, and that the health system needs to continuously monitor and support people from that point forward, not just after their last chemo session.

I read that and think: exactly. The hardest moment isn’t three years into survivorship — it’s the first week. The first phone call. The first time someone hears “biopsy” and “stage” and “options” all in the same breath. That’s the moment our industry has underserved the most, and it’s the moment I built my company around.

What survivors bring that clinicians often can’t

I’m not alone in this conviction — it’s showing up in how leading cancer centers are formalizing survivor input into research and care itself. At MUSC’s Hollings Cancer Center, survivor advocate Angela Timashenka Geiger has spent recent months representing the Survivorship and Cancer Outcomes Research (SCOR) Initiative at national research meetings, including the American Association for Cancer Research’s Scientist↔Survivor Program — a competitive training pipeline that embeds patient advocates directly into scientific conversations about the future of cancer care. Geiger now chairs SCOR’s Survivor Working Group and sits on its external advisory board. Of that initiative, she said what stands out to her is that a surgeon is personally leading the effort to make survivorship central to serious research and clinical practice.

The clinical literature backs up why survivor voice matters so much, and it’s the evidence base I keep coming back to. A pilot evaluation of the “Stronger Together” peer mentoring model — an adaptation of the Woman to Woman program originated at Mount Sinai — paired newly diagnosed breast and gynecologic cancer patients in Vietnam with trained survivor volunteers. The study found measurable improvements in depression, self-efficacy, and perceived social support, with the sharpest gains appearing within the first two months of contact — precisely the window when patients are most overwhelmed and least oriented. A broader systematic review of peer-to-peer cancer support programs likewise found that people affected by cancer offer each other something distinct from professional psychosocial care: support rooted in shared, lived experience rather than clinical training alone. Mayo Clinic’s long-running Pink Ribbon Mentorship Program for newly diagnosed breast cancer patients was built on that same premise — that survivors, working alongside the medical team, can reach patients in a way clinicians structurally cannot.

The thread running through all of it is one I’ve built my whole platform around: peer support doesn’t replace medical expertise. It fills the gap medicine alone can’t close — the gap between clinical information and lived understanding.

Taking survivor guidance online, at scale

Here’s where I think the industry still has work to do. The research above is powerful, but it mostly describes in-person or phone-based mentoring — a survivor and a patient, matched locally, meeting when a program happens to exist and a mentor happens to be available. That’s meaningful, but it doesn’t reach most people. Most newly diagnosed patients don’t have access to a hospital-run mentorship program in their first week. They have a search bar.

That’s the gap XpertGuided was built to close. It pairs survivor testimony with AI-powered personalization to meet patients at the single hardest moment of the journey: the beginning, when a diagnosis is brand new, the system feels impossible to navigate, and a late-night internet spiral can do more harm than good. If survivor-informed peer support measurably lowers distress and builds self-efficacy in a clinical trial setting, then I don’t think it’s a stretch to say the same principle belongs at the center of online health education generally — not as a sidebar or a “patient story” tacked onto a page of clinical facts, but as the actual architecture of how that education is delivered.

Why this model deserves to be the standard, not the exception

Put the pieces together and the picture is clear to me:

• The population needing this support is enormous and growing — nearly a thousand new survivors a day, per ACS estimates.
• The evidence is specific about timing — peer and survivor support delivers its biggest psychological benefit in the earliest weeks after diagnosis, exactly when most patients are navigating alone.
• Institutions are already formalizing survivor voice — Hollings’ SCOR Initiative and AACR’s Scientist↔Survivor Program show that leading cancer centers now treat survivor perspective as core to research and care design, not a nice-to-have.
• Digital platforms can encode that same principle at scale — which is exactly what I built XpertGuided to do: put a real, guided human perspective in front of every new patient, not just the fortunate few who find a local mentorship program.

None of this diminishes the role of oncologists, nurses, and care teams — the evidence is clear that survivor support works alongside clinical care, not in place of it. But as the survivor population swells past 22 million in the next decade, I keep coming back to the question Dr. Kamal poses about survivorship care broadly: whether patients get “more of their best days” — starting from the moment they’re told they have cancer, not months later, once the system finally catches up to them. That’s the standard I want every health education platform, including my own, to be held to.